Industry Partners
Partnering with the leading academic, industry, and government research institutions
In collaboration with Protein Biotechnologies, BioServe now offers the SomaPlex™ Reverse Phase Protein Microarray. These products combine serum samples from BioServe’s Global BioRepository with the custom microarray expertise of Protein Biotechnologies.
SomaPlex™ Reverse Phase Protein Microarrays rapidly profile protein expression in serum collected from human cancer patients. Its ability to simultaneously identify multiple proteins in multiple serum specimens has broad applications in biological and biomedical research, and responds to an increasing demand for high-throughput screening of protein targets from multiple specimens.
Each microarray contains a serum sample with complete demographic and relevant clinical disease-specific data. The microarray utilizes an antibody directed against a specific protein target to determine protein expression, yet the versatility of the tool allows it to be adapted to other protein-specific probes, such as labeled peptides, proteins, nucleic acids, or drugs/ligands.
A range of detection systems can be employed for visualization of the resulting antibody binding, including color development, enhanced chemiluminescence (ECL) and fluorescence. The captured image is subsequently processed and analyzed using commercially available high-resolution scanners or instruments equipped with a charged coupled device (CCD) camera.
Each serum specimen is spotted in duplicate at six different serum concentrations, in the proprietary Zeptoblock™ Protein Microarray Blocking Buffer that permits most soluble proteins to retain their native, or non-denatured, structure and activity. Different stages of disease progression are represented, and within each stage specimens are included for positive and negative progesterone and estrogen receptors. This breast cancer serum microarray is the first in a series of cancer-specific microarrays under development.
About Protein Biotechnologies
Protein Biotechnologies manufactures and supplies human clinical specimen derivatives, protein and tissues microarray research products and services to pharmaceutical, biotechnology, government and academic institutions worldwide. The company provides high throughput, proteomic solutions to understand the cause of human disease and accelerate discoveries for the diagnosis and treatment of cancer, diabetes / obesity, allergies, neurodegenerative, cardiovascular, inflammatory, and autoimmune disease research. Protein Biotechnologies’ research and development goals are focused on creating innovative solutions for high throughput biomarker screening and molecular fingerprinting of protein and nucleic acids using one of the largest sources of high quality, well characterized clinical specimens in the world. For more information visit www.proteinbiotechnologies.com
BioServe now offers DNA Genotek’s Oragene.DNA sample collection kits as part of our DNA and RNA extraction and genotyping service. BioServe now offers customers a comprehensive sample and testing platform combining RNA and DNA sample collections that feature extraction and genetic analysis from saliva.
With Oragene.DNA sample collection kits as part of BioServe’s Genomic Services, clients have the flexibility of an easy, reliable and non-invasive self-collection of saliva samples. As part of this relationship, BioServe has joined the DNA Genotek Partner Program.
This partnership represents BioServe’s validation of Oragene.DNA kits for use within its DNA and RNA extraction and genotyping service, including sample quantification and normalization; whole genome amplification; multiplex-based genotyping, expression analysis and sample archiving.
About DNA Genotek
DNA Genotek develops products that optimize ease of collection and provide superior samples and proven performance for those requiring high-quality biological samples for nucleic acid testing. High-quality samples that are easily collected from target populations enable our customers to focus on translating their analysis and testing into significant worldwide advancements in health and science. DNA Genotek's success is based on our strong relationship with our valued customers, our innovative environment and our passion for quality.
Today, DNA Genotek products are marketed worldwide and support thousands of customers as they achieve breakthroughs in genomic research, in diagnostics laboratories, in the pharmaceutical industry and in personal genomics. Consequently, our products provide our customers with the ability to focus on solving disease, disease prevention and treatment by translating their testing into worldwide health improvements.
As a leading provider of CLIA-certified genetic testing services, BioServe provides NGC Medical with a full complement of CLIA-certified personalized genomics services, including DNA extraction, QC DNA, and control DNA for NGC’s NutriGenCode validation.
NutriGeneCode is a simple, non-invasive saliva test able to identify 50 of the most significant Single Nucleotide Mutations (SNPs) involved in cellular aging and consequent body response, such as lipid and carbohydrate metabolism, hypertension, inflammation, oxidation and detoxification reactions and DNA repair. NutriGeneCode tests are a key component of NGC’s innovative personal genetic health program, which provides personalized nutraceutical recommendations based on a person’s genetic profile.
About NGC Medical
With more than 20 years of experience in the Italian health sector, NGC Medical is market leader in building and managing public and private hospital departments, including Interventional Cardiology, Electrophysiology and Interventional Radiology catheterization laboratories, Cardiac Surgery units and Intensive Care units.
NGC Medical also manufactures and distributes cutting edge medical devices and designs and builds operating rooms, intensive care units and catheterization laboratories.